Welcome to the Tirzepatide Weight Loss Program
Excited to Begin Your Weight Loss Journey? We Are Too!
IVY RX is excited to help you take the first step towards a healthier you. As we age, our systems naturally slow down and don’t operate at the same capacity they used to. This is especially true regarding weight loss. However, weight loss treatment has come a long way from fad diets and unsustainable or even dangerous weight loss methods.
Compounded Tirzepatide injections are leading the way in weight loss innovation. IVY RX is here to guide you on your wellness journey by providing a convenient solution to incorporate into your daily routine.
Your Introduction to Tirzepatide Injections
Before starting your injection regimen, we want to ensure you have all the information needed to stay on track and achieve your desired results.
This introduction will cover the following:
- How we tailor your treatment plan.
- Dosage schedule & medication administration.
- Everything you want to know about Tirzepatide injections
- Side effects & special considerations
- Important information on Tirzepatide
Welcome to the New Version of You
IVY RX welcomes you to our program and supports you in taking your first step towards a new you with Tirzepatide. This groundbreaking obesity treatment has the potential to enhance your quality of life while helping you achieve longevity and optimal wellness.
Your Weight Loss Journey on Tirzepatide
Your Tirzepatide regimen may produce modest results initially, but as you continue on your wellness path, your weight loss results will become more pronounced.
It’s important to note that Tirzepatide treatment may result in vitamin B12 deficiency. For this reason, we create a compounded treatment tailored to your unique bodily needs.
Below is a detailed breakdown of your Tirzepatide treatment schedule for the next 20+ weeks:
Short-term Effects: Weeks 1 - 4
During the first four weeks of your Tirzepatide treatment, your body will adjust and adapt. You should expect to feel significantly fuller after meals and experience reduced hunger overall. Noticeable side effects may include nausea as the dosage increases. Weight loss during the first month may be gradual.
Initial Prescribed
Dosage:
Tirzepatide: 2.5 mg
Methylcobalamin: 100mcg/mL per dose (0.25mg/0.1mg)
Mid-term Effects: Weeks 5 - 20
Midway through your Tirzepatide journey, you will experience a continued decrease in cravings and hunger pangs, with reduced side effects. Due to your drastically reduced caloric intake, your results will be more pronounced at this point. You may also experience other health benefits, including a reduced risk of cardiometabolic problems and regulated blood pressure.
Prescribed Dosage: Your dosage will increase
accordingly.
Long-term Effects: Longer than 20 weeks
In the later stages of your Tirzepatide treatment, you’ll likely be close to or have achieved your target weight. You will experience an enhanced quality of life, greater physical abilities, and maintain healthier cardiometabolic levels. As your body adapts to your new caloric intake and metabolic rate, your weight loss will stabilize.
However, every situation varies, and your body may respond differently than others. We encourage you to contact your provider should you have any concerns about your progress so we can develop the best plan moving forward.
Prescribed Dosage: Maintenance or otherwise as
prescribed by your provider.
Important Things to Know
As with any treatment regimen, you may experience side effects as your body adjusts to Tirzepatide. Should any side effects become problematic or impact your daily life, seek medical attention as soon as possible.
Special Considerations
To maximize treatment results, administer your injections first thing in the morning without food or other medications. Wait 30 minutes before taking any other medicines following your injection.
Most Common Side Effects of Tirzepatide Treatment
Side effects are common when first starting Tirzepatide treatment. They should diminish as your body adjusts. You may experience:
- Nausea
- Abdominal pain
- Constipation
- Vomiting
- Diarrhea
- Decreased appetite
Seek immediate medical attention if you experience the following:
- Severe gastrointestinal distress: Symptoms like uncontrollable nausea, vomiting, or diarrhea could lead to dehydration and worsen any pre-existing kidney conditions.
- Trouble swallowing, breathing, or swelling in your neck: These symptoms could indicate a serious thyroid condition known as a Thyroid C-cell tumor.
- Severe back pain: Persistent back pain could indicate pancreatitis, which can have life-threatening complications if untreated.
- Vision changes: This could signal diabetic retinopathy, experienced in patients with type 2 diabetes.
- Pain in the upper right/middle stomach: This could indicate issues with your gallbladder, such as gallstones or inflammation, with symptoms including fever, yellow skin or eyes, nausea, and vomiting.
FAQs
Is compounded Tirzepatide safe?
There is no evidence that compounded Tirzepatide negatively impacts health or weight loss results if you are a qualified candidate for the treatment. Compounded Tirzepatide treatment contains the same active ingredients shown to produce results in name-brand GLP-1 agonists.
How long will it take for me to receive my treatment?
IVY RX strives to provide a swift turnaround once your order is approved. Typically, it takes 3 - 5 business days for processing. However, if treatment is in high demand, it could take around 7 - 10 business days.
How does self-administration work?
Compounded Tirzepatide requires a subcutaneous injection. While this can be daunting for some, we ensure you have all the knowledge needed to administer your treatment confidently. Our team is available for any questions and will provide guidance on how to draw the injection, store it, and administer it.
Who should not use Tirzepatide?
Those who have been diagnosed with or have a history of the following should not take Tirzepatide:
- Kidney disease
- Type 1 Diabetes
- Diabetic ketoacidosis
- Thyroid cancer
- Pancreatitis
- Multiple endocrine neoplasia syndrome type 2 (MEN 2)